Search research articles
Contact Us
Filters
Showing results (741-750 of 846) with videos related to
Page
of 85
Sort By:
Parasites & Vectors
|
June 27, 2015
Ubiquitin-specific proteases are differentially expressed throughout the Schistosoma mansoni life cycle
Roberta V Pereira, Matheus de S Gomes, Roenick P Olmo, et al.
Journal of Gastroenterology and Hepatology
|
March 21, 2017
Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma
T Miyata, Y Yamashita, T Yamao, et al.
Carcinogenesis
|
February 24, 1998
Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation
J M Kim, S Araki, D J Kim, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
July 1, 2015
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma
K Harada, S Ida, Y Baba, et al.
BJS Open
|
October 9, 2019
Multicentre study of perioperative <i>versus</i> adjuvant chemotherapy for resectable colorectal liver metastases
M-A Allard, Y Nishioka, N Beghdadi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
February 15, 2018
Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer
K Kosumi, N Yoshida, K Okadome, et al.
ESMO Open
|
October 9, 2021
Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5)
Y Tanaka, H Takeuchi, Y Nakashima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study
S Iwamoto, T Takahashi, H Tamagawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
M Ueno, T Okusaka, Y Omuro, et al.
The British Journal of Surgery
|
February 1, 2020
Risk model for severe postoperative complications after total pancreatectomy based on a nationwide clinical database
D Hashimoto, M Mizuma, H Kumamaru, et al.
Page
of 85
Search research articles
Search
Showing results (741-750 of 846) with videos related to
Sort By:
Page
of 85
Parasites & Vectors
|
June 27, 2015
Ubiquitin-specific proteases are differentially expressed throughout the Schistosoma mansoni life cycle
Roberta V Pereira, Matheus de S Gomes, Roenick P Olmo, et al.
Journal of Gastroenterology and Hepatology
|
March 21, 2017
Hepatobiliary and Pancreatic: Hepatocellular carcinoma developed with angiomyolipoma
T Miyata, Y Yamashita, T Yamao, et al.
Carcinogenesis
|
February 24, 1998
Chemopreventive effects of carotenoids and curcumins on mouse colon carcinogenesis after 1,2-dimethylhydrazine initiation
J M Kim, S Araki, D J Kim, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
July 1, 2015
Prognostic and clinical impact of sarcopenia in esophageal squamous cell carcinoma
K Harada, S Ida, Y Baba, et al.
BJS Open
|
October 9, 2019
Multicentre study of perioperative <i>versus</i> adjuvant chemotherapy for resectable colorectal liver metastases
M-A Allard, Y Nishioka, N Beghdadi, et al.
Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus
|
February 15, 2018
Minimally invasive esophagectomy may contribute to long-term respiratory function after esophagectomy for esophageal cancer
K Kosumi, N Yoshida, K Okadome, et al.
ESMO Open
|
October 9, 2021
Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5)
Y Tanaka, H Takeuchi, Y Nakashima, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 25, 2015
FOLFIRI plus bevacizumab as second-line therapy in patients with metastatic colorectal cancer after first-line bevacizumab plus oxaliplatin-based therapy: the randomized phase III EAGLE study
S Iwamoto, T Takahashi, H Tamagawa, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 19, 2015
A randomized phase II study of S-1 plus oral leucovorin versus S-1 monotherapy in patients with gemcitabine-refractory advanced pancreatic cancer
M Ueno, T Okusaka, Y Omuro, et al.
The British Journal of Surgery
|
February 1, 2020
Risk model for severe postoperative complications after total pancreatectomy based on a nationwide clinical database
D Hashimoto, M Mizuma, H Kumamaru, et al.
Page
of 85